Opendata, web and dolomites

THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (United Kingdom): list of projects

The following table shows the list of Horizon 2020 projects developed by "THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY". Projects are ordered by starting date.

Click on table headers to rearrange data.

# acronym  programme  role  EC contrib.  start  views 
1 DO-IT   H2020-EU.3.1.7. participant 0.00 2017-02-01 1038
2 PARADIGM   H2020-EU.3.1.7. participant 0.00 2018-03-01 604
totale 0.00

Network analysis

This organization collaborated with partners in 15 countries.

 DO-IT

Within the project DO-IT this organization got in touch with:

role cy shortname name
participant UK HIQ HEALTH IQ LIMITED (PRC)
participant DE Bayer BAYER AKTIENGESELLSCHAFT (PRC)
participant SE IHE IHE, INSTITUTET FOR HALSO- OCH SJUKVARDSEKONOMI AKTIEBOLAG (PRC)
participant NO NoMA STATENS LEGEMIDDELVERK (PUB)
participant CH Celgene CELGENE MANAGEMENT SARL (PRC)
participant BE UCB UCB BIOPHARMA SRL (PRC)
participant BE EFPIA FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH)
participant SE TLV TANDVARDS-OCH LAKEMEDELSFORMANSVERKET (PUB)
participant ES FI ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA (OTH)
participant DE VFA VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH)
participant BE EMSP THE EUROPEAN MULTIPLE SCLEROSIS PLATFORM AISBL (OTH)
participant US MSD MERCK SHARP & DOHME CORP (PRC)
participant BE ECPC EUROPEAN CANCER PATIENT COALITION (OTH)
participant DE TMF TMF - TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV (REC)
participant UK NICE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB)
participant BE Amgen AMGEN (PRC)
participant UK ELI LILLY Eli Lilly and Company Limited (PRC)
participant FR IRIS INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC)
participant DE InterSystems INTERSYSTEMS GMBH (PRC)
participant UK Pfizer PFIZER LIMITED (PRC)
participant FR SARD SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC)
participant DE BI BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC)
participant BE JANSSEN JANSSEN PHARMACEUTICA NV (PRC)
participant NO NIPH FOLKEHELSEINSTITUTTET (REC)
participant CH ROCHE F. HOFFMANN-LA ROCHE AG (PRC)
participant CH NOV NOVARTIS PHARMA AG (PRC)
participant IT CERGAS UNIVERSITA COMMERCIALE LUIGI BOCCONI (HES)
participant HU SU SEMMELWEIS EGYETEM (HES)
coordinator UK LSE LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE (HES)
participant UK GSK GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC)
participant DK Novo NOVO NORDISK A/S (PRC)
participant DE Merck MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC)
participant UK ULIV THE UNIVERSITY OF LIVERPOOL (HES)
participant UK Imperial IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES)
participant FR INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC)

 PARADIGM

Within the project PARADIGM this organization got in touch with:

role cy shortname name
participant BE Alexion ALEXION SERVICES EUROPE SPRL (PRC)
participant CA HTAi HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH)
participant BE Synergist THE SYNERGIST (OTH)
participant DE Bayer AG BAYER AKTIENGESELLSCHAFT (PRC)
participant BE UCB UCB BIOPHARMA SRL (PRC)
participant IT AIFA AGENZIA ITALIANA DEL FARMACO (PRC)
participant UK Amgen AMGEN LIMITED (PRC)
participant BE EFPIA FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH)
participant NL STICHTING VU STICHTING VU (HES)
participant DE VFA VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH)
participant FR EURORDIS EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH)
participant DE GRT GRUNENTHAL GMBH (PRC)
participant UK Covance COVANCE LABORATORIES LTD (PRC)
participant US MSD MERCK SHARP & DOHME CORP (PRC)
participant ES SYNAPSE SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC)
participant UK Eli Lilly Eli Lilly and Company Limited (PRC)
participant FR IRIS INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC)
participant LU AE ALZHEIMER EUROPE (OTH)
participant UK PFIZER PFIZER LIMITED (PRC)
participant FR SARD SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC)
participant BE JANSSEN JANSSEN PHARMACEUTICA NV (PRC)
participant ES IACS INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC)
participant DE EATG EUROPEAN AIDS TREATMENT GROUP EV (OTH)
coordinator LU EPF FORUM EUROPEEN DES PATIENTS (FPE) (OTH)
participant ES FSJD FUNDACIO SANT JOAN DE DEU (REC)
participant CH ROCHE F. HOFFMANN-LA ROCHE AG (PRC)
participant CH NOVARTIS NOVARTIS PHARMA AG (PRC)
participant DK Lundbeck H. LUNDBECK AS (PRC)
participant UK GSK GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC)
participant DK Novo Nordisk NOVO NORDISK A/S (PRC)
participant BE EFGCP EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH)
participant DE Merck MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC)
participant UK UOXF THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES)